2016
DOI: 10.1056/nejmcp1513724
|View full text |Cite|
|
Sign up to set email alerts
|

Postmenopausal Osteoporosis

Abstract: Key Clinical Points Postmenopausal Osteoporosis Fractures and osteoporosis are common, particularly among older women, and hip fractures can be devastating. Treatment is generally recommended in postmenopausal women who have a bone mineral density T score of -2.5 or less, a history of spine or hip fracture, or a Fracture Risk Assessment Tool (FRAX) score indicating increased fracture risk. Bisphosphonates (generic) and denosumab reduce the risk of hip, nonvertebral, and vertebral fractures; bisphosphonates are… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

6
827
0
68

Year Published

2016
2016
2021
2021

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 1,264 publications
(952 citation statements)
references
References 50 publications
6
827
0
68
Order By: Relevance
“…⑤ Given extremely low incidence of BRONJ in osteoporosis, the benefits of BP for fracture prevention outweigh the risks for BRONJ [35].…”
Section: Mechanism Of Aronjmentioning
confidence: 99%
“…⑤ Given extremely low incidence of BRONJ in osteoporosis, the benefits of BP for fracture prevention outweigh the risks for BRONJ [35].…”
Section: Mechanism Of Aronjmentioning
confidence: 99%
“…In osteoporosis, bones become sensitive due to decrease in bone mass caused by factors related with genetics, hormonal, environmental and diet and bone loss occurs in the endostal region of the skeleton [2]. One of the main reasons of osteoporosis is the deficiency in estrogen.…”
Section: Introductionmentioning
confidence: 99%
“…Basically, osteoporosis can occur at any age, but it increases in older people [1]. Due to the demographic development (especially, the increasing life expectancy in coming decades), this numbers are expected to increase in the future.…”
Section: Introductionmentioning
confidence: 99%